Intrasubunit and Intersubunit Steroid Binding Sites Independently and Additively Mediate α1β2γ2L GABAA Receptor Potentiation by the Endogenous Neurosteroid Allopregnanolone
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 100 (1) , 19-31
Abstract
Prior work employing functional analysis, photolabeling, and X-ray crystallography have identified three distinct binding sites for potentiating steroids in the heteromeric GABAA receptor. The sites are located in the membrane-spanning domains of the receptor at the β-α subunit interface (site I) and within the α (site II) and β subunits (site III). Here, we have investigated the effects of mutations to these sites on potentiation of the rat α1β2γ2L GABAA receptor by the endogenous neurosteroid allopregnanolone (3α5αP). The mutations were introduced alone or in combination to probe the additivity of effects. We show that the effects of amino acid substitutions in sites I and II are energetically additive, indicating independence of the actions of the two steroid binding sites. In site III, none of the mutations tested reduced potentiation by 3α5αP, nor did a mutation in site III modify the effects of mutations in sites I or II. We infer that the binding sites for 3α5αP act independently. The independence of steroid action at each site is supported by photolabeling data showing that mutations in either site I or site II selectively change steroid orientation in the mutated site without affecting labeling at the unmutated site. The findings are discussed in the context of linking energetic additivity to empirical changes in receptor function and ligand binding. SIGNIFICANCE STATEMENT Prior work has identified three distinct binding sites for potentiating steroids in the heteromeric γ-aminobutyric acid type A receptor. This study shows that the sites act independently and additively in the presence of the steroid allopregnanolone and provide estimates of energetic contributions made by steroid binding to each site.Keywords
This publication has 42 references indexed in Scilit:
- Monod–Wyman–Changeux allosteric mechanisms of action and the pharmacology of etomidateCurrent Opinion in Anaesthesiology, 2012
- Two Etomidate Sites in α1β2γ2 γ-Aminobutyric Acid Type A Receptors Contribute Equally and Noncooperatively to Modulation of Channel GatingAnesthesiology, 2012
- Occupation of Either Site for the Neurosteroid Allopregnanolone Potentiates the Opening of the GABAA Receptor Induced from Either Transmitter Binding SiteMolecular Pharmacology, 2011
- Steroid Interaction with a Single Potentiating Site Is Sufficient to Modulate GABA-A Receptor FunctionMolecular Pharmacology, 2009
- Long-Range Coupling in an Allosteric Receptor Revealed by Mutant Cycle AnalysisBiophysical Journal, 2009
- Mutations of the GABA-A Receptor α1 Subunit M1 Domain Reveal Unexpected Complexity for Modulation by Neuroactive SteroidsMolecular Pharmacology, 2008
- Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA‐A receptor potentiationThe Journal of Physiology, 2007
- Natural and Enantiomeric Etiocholanolone Interact with Distinct Sites on the Rat α1β2γ2L GABAA ReceptorMolecular Pharmacology, 2007
- Revealing the Architecture of a K + Channel Pore Through Mutant Cycles with a Peptide InhibitorScience, 1995
- On the nature of allosteric transitions: A plausible modelJournal of Molecular Biology, 1965